Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Natividad, Josephine"'
Autor:
Jadus, Martin R.1,2,3,4 martin.jadus@va.gov, Natividad, Josephine1, Mai, Anthony1, YiOuyang1,2, Lambrecht, Nils1, Szabo, Sandor2,4, Ge, Lisheng1, Hoa, Neil1, Dacosta-Iyer, Maria G.1,2
Publikováno v:
Clinical & Developmental Immunology. 2012, p1-21. 21p. 1 Color Photograph, 1 Diagram, 2 Charts.
Autor:
Ge, Lisheng, Hoa, Neil, Bota, Daniela A., Natividad, Josephine, Howat, Andrew, Jadus, Martin R.
Publikováno v:
Clinical and Developmental Immunology.
Treatment of brain cancers, especially high grade gliomas (WHO stage III and IV) is slowly making progress, but not as fast as medical researchers and the patients would like. Immunotherapy offers the opportunity to allow the patient's own immune sys
Autor:
Lisheng Ge, Hoa, Neil, Bota, Daniela A., Natividad, Josephine, Howat, Andrew, Jadus, Martin R.
Publikováno v:
Clinical & Developmental Immunology; 2010, p1-19, 19p, 1 Diagram, 1 Chart
Autor:
Neil Hoa, Maria Dacosta-Iyer, Sandor Szabo, Martin R. Jadus, Lisheng Ge, Nils Lambrecht, Yi Ouyang, Anthony Mai, Josephine Natividad
Publikováno v:
Clinical and Developmental Immunology, Vol 2012 (2012)
Jadus, Martin R; Natividad, Josephine; Mai, Anthony; Ouyang, Yi; Lambrecht, Nils; Szabo, Sandor; et al.(2012). Lung Cancer: A Classic Example of Tumor Escape and Progression While Providing Opportunities for Immunological Intervention. Clinical and Developmental Immunology, 2012, 1-21. doi: 10.1155/2012/160724. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/78n8r86t
Clinical and Developmental Immunology
Jadus, Martin R; Natividad, Josephine; Mai, Anthony; Ouyang, Yi; Lambrecht, Nils; Szabo, Sandor; et al.(2012). Lung Cancer: A Classic Example of Tumor Escape and Progression While Providing Opportunities for Immunological Intervention. Clinical and Developmental Immunology, 2012, 1-21. doi: 10.1155/2012/160724. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/78n8r86t
Clinical and Developmental Immunology
Lung cancers remain one of the most common and deadly cancers in the world today (12.5% of newly diagnosed cancers) despite current advances in chemo- and radiation therapies. Often, by the time these tumors are diagnosed, they have already metastasi